62 results on '"Van Rhijn B"'
Search Results
2. Stage dependent survival in patients treated with NAC and RC: Implications for patient selection and adjuvant therapy
3. Factores de riesgo de enfermedad residual en la re-RTU en una gran cohorte de pacientes con enfermedad T1G3
4. Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients
5. OC-0103 Comparative study of brachytherapy vs. radical cystectomy for cT1-2 muscle-invasive bladder cancer
6. Urotheelcelcarcinoom
7. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study
8. Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
9. Risk tables for predicting progression using the 1973 and 2004/2016 WHO grading classification systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study
10. Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades
11. L’impact de l’intoxication tabagique sur la réponse à la chimiothérapie néoadjuvante à base de sels de platine chez les patients traités pour carcinome urothélial de vessie – étude prospective multicentrique
12. Carcinome urothélial au sein d’un diverticule de vessie : étude multicentrique des caractéristiques cliniques, anatomopathologiques et des résultats oncologiques
13. Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy
14. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
15. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought
16. Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients
17. Cigarette smoking is adversely associated with pathological response to platinum-based neoadjuvant chemotherapy in patients undergoing treatment for urinary bladder cancer
18. Value of repeated ureterorenoscopy within the first 3 months after endoscopic treatment in upper tract urothelial carcinoma (UTUC)
19. Biological characterization of cisplatin-resistant bladder cancer: Implications for second-line treatments?
20. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer
21. The impact of cigarette smoking on adverse pathological features and survival in patients undergoing radical cystectomy for urinary bladder cancer - a prospective, European multicenter study of the EAU young academic urologists urothelial carcinoma group
22. Disease and patient’s characteristics in elderly (≥75 years) treated with radical cystectomy: results of a large multicentre retrospective series
23. Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube
24. Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20-year results from a nationwide pathology database
25. Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
26. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
27. Pre-radiotherapy, (robot-assisted) laparoscopic sentinel node dissection and its impact on recurrence and progression of prostate cancer
28. Metric sub-stage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
29. The prognostic role of sentinel node dissection on biochemical recurrence-free survival rate of prostate cancer patients after robot-assisted radical prostatectomy
30. HIPEC with cytoreductive surgery can cure patients with limited peritoneal carcinomatosis from adenocarcinoma of the urachus
31. Recurrence and progression according to stage at re-TUR in t1g3 bladder cancer patients treated with BCG: Not as bad as previously thought
32. Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients
33. The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis
34. 1146 CT imaging as a diagnostic tool for response evaluation in bladder cancer patients following neoadjuvant chemotherapy
35. 508 The impact of cigarette smoking and smoking cessation on oncological aggressiveness at radical cystectomy – a prospective, European, multicenter study of the EAU Young Academic Urologists (YAU) bladder cancer working group
36. 1016 Are continent urinary diversions feasible at the time of radical cystectomy after pelvic radiotherapy? Analysis of a large retrospective multicenter series
37. 620 Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases
38. 1147 Neutrophil-to-lymphocyte ratio as a predictor of response to neo-adjuvant chemotherapy in muscle-invasive bladder cancer
39. 899 Benign uretero-ileal strictures after urinary diversion: Endo-urological treatment versus open surgical revision
40. Editorial: is eosinophilic oesophagitis different to proton pump inhibitor‐responsive oesophageal eosinophilia?
41. 532 Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1?
42. Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept
43. 900 Sub-stage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
44. 1001 The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG
45. 412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer
46. Disease duration determines health-related quality of life in adult eosinophilic esophagitis patients
47. Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis
48. 4 Robotgeassisteerde laparoscopische prostatectomie met een schildwachtklierprocedure op geleide van fluorescentie en radioactiviteit
49. 697 Prognostic factors and risk groups in T1G3 patients initially treated with BCG: Results of a multicenter retrospective series in 1743 patients
50. Rapidly increasing incidence of eosinophilic esophagitis in a large cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.